跳至主要内容
临床试验/ISRCTN17318966
ISRCTN17318966已完成未知

Improving understanding and recall of risk information relating to multiple sclerosis medication - developing an evidence-based clinical tool for assisting communication and understanding of multiple sclerosis medication risk information between patients and health professionals

Royal Holloway, University of London0 个研究点目标入组 24 人开始时间: 2016年10月26日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
24

研究概览

简要总结

2021 results in https://pubmed.ncbi.nlm.nih.gov/33513520/ (added 01/02/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of relapsing-remitting multiple sclerosis (RRMS) by a consultant neurologist to best current criteria (i.e. not clinically isolated syndrome (CIS), likely Polman et al., 2011)
  • 2. Able and willing to give informed consent
  • 3. Able to meet tasks demands of study in terms of sensorimotor abilities
  • 4. Ages 18 to 60

排除标准

  • 1. Significant change in medication in last 4 weeks
  • 2. Relapse recovery within last 4 weeks
  • 3. Significant psychiatric history/condition
  • 4. Significant medical condition (other than MS), personal or social circumstances likely to influence study participation

研究者

相似试验